Abstract: A sash includes a stile, the stile defining a first flange and a second flange, a locking slot defined extending through the first flange; and a sash guide, the sash guide defining a first guide leg and a second guide leg, the first guide leg defining a locking tab, the locking tab extending through the locking slot.

Abstract: Systems and methods for emulator detection are disclosed. In one embodiment, a user agent string may be embedded into a first numerical data vector representation. Hardware characteristics of a client device corresponding to the user agent may be embedded into a second numerical data vector representation. Based on the first numerical data vector representation of the user agent and the second numerical data vector representation of the hardware characteristics, and their consistency, the client device may be determined to be an emulator or a non-emulator device.

Abstract: Based on replay of a thread, one implementation observes an influx of a value of a memory cell comprising an interaction between the thread and the value of the memory cell at an execution time point in the replaying, and determines whether the value of the memory cell observed from the influx is inconsistent with a prior value of the memory cell as known by the thread at the execution time point. If so, this implementation initiates an indication of a data inconsistency. Based on replay of a plurality of threads, another implementation identifies a memory cell that was accessed by a first thread while a thread synchronization mechanism was active on the first thread. Then, if there was another access to the memory cell by a second thread without use of the thread synchronization mechanism, this implementation initiates an indication of a potential data contention.

Abstract: Methods are described for driving an electro-optic display having a plurality of display pixels. Each of the display pixels is associated with a display transistor. The method includes the following steps in order. A first voltage is applied to a first display transistor associated with a first display pixel of the plurality of display pixels. The first voltage is applied during at least one frame of a driving waveform. A second voltage is applied to the first display transistor associated with the first display pixel. The second voltage has a non-zero amplitude less than the first voltage and is applied during the last frame of the driving waveform.

Abstract: The disclosure pertains to a capacitively coupled plasma source in which VHF power is applied through an impedance-matching coaxial resonator having a symmetrical power distribution.

Abstract: An electronic device can include a NVM cell. The NVM cell can include a drain/source region, a source/drain region, a floating gate electrode, a control gate electrode, and a select gate electrode. The NVM cell can be fabricated using a process flow that also forms a power transistor, high-voltage transistors, and low-voltage transistors on the same die. A relatively small size for the NVM can be formed using a hard mask to define a gate stack and spacer between gate stack and select gate electrode. A gate dielectric layer can be used for the select gate electrode and transistors in a low-voltage region and allows for a fast read access time.

Abstract: A variety of methods for driving electro-optic displays so as to reduce visible artifacts are described. Such methods include (a) applying a first drive scheme to a non-zero minor proportion of the pixels of the display and a second drive scheme to the remaining pixels, the pixels using the first drive scheme being changed at each transition; (b) using two different drive schemes on different groups of pixels so that pixels in differing groups undergoing the same transition will not experience the same waveform; (c) applying either a balanced pulse pair or a top-off pulse to a pixel undergoing a white-to-white transition and lying adjacent a pixel undergoing a visible transition; (d) driving extra pixels where the boundary between a driven and undriven area would otherwise fall along a straight line; and (e) driving a display with both DC balanced and DC imbalanced drive schemes, maintaining an impulse bank value for the DC imbalance and modifying transitions to reduce the impulse bank value.

Abstract: Systems and methods are provided for automatedly troubleshooting a computing application (e.g., a cloud-based computing application). An application domain of the computing application is modeled as a two-dimensional array of cells, a first dimension of the array representing components or microservices of the application domain, and a second dimension of the array representing states of the components or microservices, the array including paths between pairs of cells in the array. A troubleshooting goal is defined as a target state of the application domain, the target state corresponding to a target cell in the array. An initial state of the application domain is also provided, the initial state corresponding to an initial cell in the array. A reinforcement-learning-trained machine-learning algorithm can determine a solution path in the array between the initial cell and the target cell. Divergence between a failure case and a solution path indicates a probable failure cause.

Abstract: Antibodies that bind the apple 3 domain of human coagulation Factor XI and inhibit activation of FXI by coagulation factor XIIa as well as activation of FIX by FXIa are described.

Abstract: This invention relates to a method for synthesizing polyoxymethylene on a substrate. The method includes depositing monomer capable of forming polyoxymethylene by an initiated polymerization reaction and an initiator, via initiated chemical vapor deposition (iCVD) onto a surface of a substrate in an initiated chemical vapor deposition reactor.

Abstract: The present invention relates to antagonist antibodies of the human calcitonin gene-related peptide (CGRP) receptor as well as bispecific antigen binding proteins derived from the anti-CGRP antibodies that bind to and inhibit both the human CGRP receptor and another target, such as the human pituitary adenylate cyclase activating polypeptide type I receptor (PAC1) receptor. Pharmaceutical compositions comprising the anti-CGRP receptor antibodies and bispecific antigen binding proteins as well as methods for producing them are also disclosed. Methods of using the anti-CGRP receptor antibodies and bispecific antigen binding proteins to ameliorate, treat, or prevent conditions associated with the CGRP and PAC1 receptors, such as chronic pain, migraine, and cluster headache, are also described.

Abstract: Systems and methods for user-agent anomaly detection are disclosed. In one embodiment, a user-agent string may be embedded into a numerical data vector representation using a sentence embedding algorithm (e.g., FastText). A predictive score may be calculated based on the numerical data vector representation and using a probability distribution function model that models a likelihood of occurrence of the observed user-agent based on patterns learned from historic payload data (e.g., a Gaussian Mixture Model). The predictive score may be compared to a threshold and, based on the comparison, it may be determined whether the user-agent is fraudulent.

Abstract: A device-management system performs processing, such as audio processing, in an instance of a virtual machine corresponding to a functionally limited (local) device. To register the local device, the device-management system receives a registration request that includes device information, encryption data, and an indication of an associated user account. The device-management system then sends this registration data to a service-provider system, which returns a shared encryption key. The device-management system and the local device may use this shared encryption key to securely communicate. The device-management system may de-allocate the instance upon detecting a period of inactivity of the local device and may re-allocate the instance when new activity is detected. The device-management system may further determine when and if audio data to be sent to the local device is encoded using a codec not implemented by the local device.

Abstract: An integrated structure for an optoelectronic device and a method of fabricating an integrated structure for an optoelectronic device.

Abstract: Methods, systems and devices are provided for communicating multimedia content over a service provider network. A network server may receive an audio-video stream from a content provider server, relaying the audio-video stream to a receiver device via the service provider network, receive an operating mode notification identifying a user behavior from the receiver device, and ceasing the relaying of the audio-video stream to the receiver device based on the user behavior. The network server may also alter the audio-video stream based on the received operating mode notification and send the altered audio-video stream to the receiver device via the service provider network.

Abstract: Antibodies that bind the apple 3 domain of human coagulation Factor XI and inhibit activation of FXI by coagulation factor XIIa as well as activation of FIX by FXIa are described.

Abstract: Based on an analysis of example content items, a proposed initial version of an application to be generated on behalf of a client is determined. At least a portion of a software program implementing the application is generated, and an indication of the software program is provided to the client. Based on input received from the client, additional operations associated with the program are initiated.

Abstract: Antibodies that bind the apple 3 domain of human coagulation Factor XI and inhibit activation of FXI by coagulation factor XIIa as well as activation of FIX by FXIa are described.

Abstract: The present disclosure generally provides compounds that antagonize certain T2R taste receptors, including related uses, methods, and compositions for the reduction of bitter taste and/or the enhancement of sweet taste. In certain aspects, the disclosure provides flavored articles or flavored compositions comprising such compounds, as well as uses of such compounds to reduce the bitter taste and/or enhance the sweet taste of such flavored articles or flavored compositions.

Abstract: Described herein are combination therapies with farnesoid X receptor (FXR) agonists, and methods of using such pharmaceutical compositions in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.